Medical access limited to dronabinol preparations; flower is not available to patients.
Austria's Narcotics Act permits medical use, but only the state agency AGES may cultivate cannabis, exporting flower to Germany for processing into dronabinol. Patients can access semi-synthetic dronabinol preparations rather than flower, under a strict prescribing process.
